Concierge cancer screening · UK
Galleri multi-cancer blood test - with honest evidence, not hype.
A single blood test analysing methylation patterns in cell-free DNA. Marketed as an early-detection tool for more than 50 cancer types. We book it, we explain the evidence and the limits, and we support you whichever way the result reads.
Why patients choose us
- 01
UK consultant sign-off
Every panel is signed off by a UKMLA-registered clinician - not a generic "results letter" with a company logo.
- 02
A conversation, not a PDF
You get a proper clinician call to walk through the results and next steps, included in every price we quote.
- 03
Independent, and free
We take no fee from providers. The recommendation is impartial and costs you nothing.
Indicative pricing
What a private Galleri test costs in the UK.
Indicative ranges across our partner blood test units. Send the details and we quote firm figures across two or three options, with cover checked.
In short
Galleri test in our network: £950, result in 2–3 weeks.
| Procedure | Indicative range | Typical duration | Stay |
|---|---|---|---|
| Galleri test with pre- and post-test consultation | £950 | 20 min clinic visit | 2–3 weeks |
| Galleri test only (existing patient) | £850 | 10 min blood draw | 2–3 weeks |
| Follow-up CT chest, abdomen, pelvis | £500–£900 | 15 min | 24–72 hours |
| Follow-up MRI (single region) | £450–£900 | 25–40 min | 3–5 working days |
| Oncology consultation if signal detected | £300–£500 | 45 min | Same or next day |
| Consultation only (no test) | £200–£400 | 30–45 min | Same visit |
Price includes the test, a pre-test consultation, and a result-review call. Any downstream imaging or biopsy is quoted separately.
The problem
Galleri is promising - but evidence is still evolving.
The NHS-Galleri trial is running through 2026, with mortality outcome data expected later. The test detects a cancer signal in a small proportion of asymptomatic people, with modest overall sensitivity and a reported specificity around 99.5%.
-
Not a replacement for screening
Mammography, cervical screening, colonoscopy and lung CT remain the mainstays for breast, cervix, colon and lung cancer.
-
Sensitivity varies by cancer and stage
Higher for symptomatic and later-stage disease; lower for early-stage cancers. A negative test does not rule out cancer.
-
A positive needs work-up
A cancer signal detected result triggers a defined imaging pathway - we walk you through it before you consent.
The journey
From enquiry to recovery - what happens, in order.
One team from first message through operation, histology and follow-up.
Phase 1 · Before
Workup, imaging, planning
Phase 2 · On the day
Theatre and recovery
Phase 3 · After
Review and follow-up
- 01
Before
Pre-test consultation
We explain the evidence, the false-positive rate and what a signal detected result would trigger.
- 02
Before
Booking and blood draw
Two 10 mL tubes at our clinic - no fasting.
- 03
Before
Sample to GRAIL
Sample shipped to the GRAIL laboratory for methylation analysis.
- 04
On the day
Turnaround
Around 2–3 weeks from draw to result.
- 05
After
Result review call
A UK clinician calls to explain either "no cancer signal detected" or "cancer signal detected".
- 06
After
If signal detected
Predicted tissue of origin drives targeted imaging (usually CT and MRI) within days.
- 07
After
Ongoing screening still applies
Whatever the result, standard organ-specific screening continues.
Typical end-to-end: 1–2 weeks from enquiry to reported scan.
When it helps
When Galleri might make sense.
Who tends to consider Galleri - and where standard screening comes first.
-
Adults over 50 with a screening interest
Most current data is in this age group; performance improves with age.
-
Family history of hard-to-screen cancers
Pancreatic, ovarian, oesophageal - cancers with no easy screening test.
-
Long-term smokers already on lung CT
Adds a broader look beyond the lung; does not replace CT.
-
BRCA/Lynch carriers - as an add-on
Adjunct only - never a replacement for surveillance mammograms, colonoscopy or MRI.
-
Prior cancer survivors
Discuss with your oncology team first - surveillance CT and MRI often already cover the ground.
-
Peace-of-mind screening
Legitimate - as long as the trade-offs (false positives, cost, downstream imaging) are clear.
-
Cancer survivors in remission
Some use Galleri to broaden surveillance; discuss with your oncologist.
-
Red flag: symptoms already present
Weight loss, blood in stool, breast lump, persistent cough - see your GP for targeted work-up, not a Galleri test.
Procedure options
Options alongside a blood-based test.
How Galleri sits next to standard screening.
-
Galleri annually or biennially
Repeat interval is not settled - annual is common in current commercial use.
-
Full-body MRI as a complement
Different modality - some prefer imaging over blood for whole-body screening.
-
NHS bowel and breast screening
FIT, colonoscopy, mammography - always in parallel.
-
Low-dose lung CT for smokers
Standard screening for eligible smokers regardless of Galleri.
-
Coronary calcium score
Different question entirely - cardiovascular, not cancer.
-
Genetic testing
BRCA/Lynch/panel testing informs baseline risk and screening strategy.
-
Tumour marker panels
CA-125, CEA, PSA - condition-specific, not multi-cancer.
-
Circulating tumour DNA (ctDNA) monitoring
For people already treated for cancer - different technology, different question.
Our vetted UK network
A small panel of clinicians, we picked them.
Consultant clinicians across London and the major UK cities. Introductions are made privately, once we understand your case.
Selection criteria
How we choose every consultant in our network.
-
CQC-registered clinics and pathology partners across the UK
-
UK GMC-registered consultants signing off every report
-
UKAS-accredited pathology labs for every blood test
-
Insurer preauth handling for Bupa, AXA, Vitality, Aviva, WPA and Cigna
Safety and recovery
What to expect afterwards - honestly.
The safety profile is well understood. What matters is choosing the right test, and reading the report honestly.
-
A blood test is safe
Two 10 mL tubes - venepuncture-level risk only.
-
False positives
Specificity around 99.5% - but in a large screened population, false alarms do occur.
-
False negatives
Sensitivity varies by cancer and stage. A negative test does not rule out cancer.
-
Downstream workload
A signal detected result triggers CT/MRI - anxiety and cost are real.
-
Not covered by insurance
UK private medical insurers do not currently cover Galleri as screening.
-
Trial data still emerging
NHS-Galleri trial reports mortality outcomes later this decade.
-
Never replaces standard screening
Mammography, cervical, colonoscopy and lung CT remain essential.
-
Best in the right person
A pre-test consultation confirms it fits your situation and preferences.
-
When to escalate
Symptoms of possible cancer trump any test - see your GP for targeted work-up.
Reading your operation note
Your operation note in four parts. Read the last one first.
Whichever centre does the scan, the report keeps to the same shape.
A quiet reminder
Surgical language is precise and can read coldly - we translate it for you.
If you would like us to talk you through the operation note and any histology before your review, just ask.
- 01 Header
Result summary
"No cancer signal detected" or "Cancer signal detected".
- 02 Signal
Predicted tissue of origin
If signal is detected, the report predicts one or two most likely origin tissues.
- 03 Interpretation
What it does and doesn’t say
A negative test does not rule out cancer; a positive test needs work-up before any diagnosis.
- 04 Next step
Recommended action
Read this first - the imaging or specialist referral we set up.
Recognised by major UK insurers
Galleri is not currently covered by UK private medical insurance. Any downstream imaging or specialist review after a positive result may be covered with a referral.
Frequently asked
Everything we get asked about galleri multi-cancer blood test.
Quick answers on approach, recovery, risks and cost.
-
What is the Galleri test?
A blood test analysing methylation patterns in circulating cell-free DNA. Marketed for early detection of a signal from more than 50 cancer types and to predict the likely tissue of origin.
-
Does the Galleri test replace mammograms or colonoscopies?
No. Organ-specific screening - mammography, cervical, colonoscopy, low-dose lung CT - remains the mainstay. Galleri is an adjunct, not a replacement.
-
How much does the Galleri test cost in the UK?
£950 including pre- and post-test consultation at our partner clinics. Any downstream imaging or specialist referral is quoted separately.
-
What happens if the test detects a cancer signal?
The report predicts a likely tissue of origin. We set up targeted imaging (usually CT and MRI) within days and, if needed, an oncology consultation. Most signals do not turn out to be cancer, so calm work-up is essential.
-
Is Galleri available on the NHS?
Not routinely. The NHS-Galleri trial is running through 2026 with mortality outcomes expected later - a wider NHS rollout depends on those results.
-
Is the Galleri test covered by UK insurance?
Not currently. It’s a self-pay decision.
Related treatments
Looking for something else?
-
Full-body MRI health screen
Whole-body imaging alternative.
Learn more -
Private CT scan
For downstream imaging after a signal.
Learn more -
Well-man health screen
Bloods, PSA and cardiovascular check.
Learn more -
Well-woman health screen
Bloods, breast, cervical, DEXA optional.
Learn more -
Private mammogram
Breast imaging pathway.
Learn more -
All tests & procedures
Every test we arrange.
Learn more